Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America

por Olivera-Botello, Gustavo, Coudeville, Laurent, Fanouillere, Karen, Guy, Bruno, Chambonneau, Laurent, Noriega, Fernando, Jackson, Nicholas
Publicado 2016

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease

por Pasin, Chloé, Halloran, M. Elizabeth, Gilbert, Peter B., Langevin, Edith, Ochiai, R. Leon, Pitisuttithum, Punnee, Capeding, Maria Rosario, Carrasquilla, Gabriel, Frago, Carina, Cortés, Margarita, Chambonneau, Laurent, Moodie, Zoe
Publicado 2018

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America

por Carpp, Lindsay N., Fong, Youyi, Bonaparte, Matthew, Moodie, Zoe, Juraska, Michal, Huang, Ying, Price, Brenda, Zhuang, Yingying, Shao, Jason, Zheng, Lingyi, Chambonneau, Laurent, Small, Robert, Sridhar, Saranya, DiazGranados, Carlos A., Gilbert, Peter B.
Publicado 2020